Bengt Thorsson and Johan Rockberg to join Atlas Antibodies’ Board of Directors
We are pleased to announce the election of Bengt Thorsson and Johan Rockberg to Atlas Antibodies’ Board of Directors, following the AGM on May 23, 2025. Åsa Riisberg has been re-elected as Chair of the Board and Catarina Flyborg, Gavin Wood, Christian Eberle and Louise Kores have been re-elected as board members. We thank Mathias Uhlén and Lotta Ljungqvist for their years of dedicated service and valuable contributions as they step down from the Board. The size of the Board remains unchanged.
4th – 6th June 2025: HistoCyte will be attending and exhibiting at the British Association of Gynaecological Pathologists 21st Annual Meeting in Collaboration with the International Society of Gynecological Pathologists in Belfast at the Assembly Buildings Conference Centre. For more information please visit https://www.thebagp.org/event/bagp-21st-annual-meeting/
3rd July 2025: HistoCyte will be attending, exhibiting, and sponsoring the South-East IHC User Group Meeting, hosted by the IHC Network in London at 1 America Square. For more information please visit https://www.theihcnetwork.com/ and submit any queries you may have.
6th – 10th September 2025: HistoCyte will be attending and exhibiting at the 37th European Congress of Pathology (ECP) In Vienna, Austria at the Austria Centre Vienna (ACV). For more information please visit https://www.esp-pathology.org/event/ecp2025/
October – November (Dates TBC): Further IHC User Group meetings will take place across the UK and Ireland, concluding with our second International Distributor Meeting in Amsterdam. For more information, please contact Craig Stamp (craig.stamp@histocyte.com) or John Tierney (john.tierney@histocyte.com).
HistoCyte welcomes Newcomer Supply!
Growing the HistoCyte reach into the USA, we welcome Newcomer Supply to our network!
We are delighted to announce a collaboration with Diaceutics. This is an exciting opportunity to work with a company that is at the forefront of understanding the oncology and pathology field. They enable pharma to understand the best approach to introducing novel drugs and how best to support the laboratories and the testing they do. We have joined their DXRX network allowing over 2500 clinical laboratories around the world to engage with us and help improve quality.
For more information, please contact info@histocyte.co.uk.
HistoCyte Partners with Cell Marque for Global Distribution
HistoCyte is delighted to announce a partnership with Cell Marque for global distribution of our products. More details can be found in the report by Business Up North.
